Mann, Elizabeth R. http://orcid.org/0000-0002-0803-0357
Lam, Ying Ka http://orcid.org/0009-0000-9881-5715
Uhlig, Holm H. http://orcid.org/0000-0002-6111-7355
Article History
Accepted: 23 February 2024
First Online: 2 April 2024
Competing interests
: H.H.U. has received research support or consultancy fees from Janssen, UCB Pharma, Eli Lilly, GSK, Celgene/BMS and AbbVie. There is no direct link between any funding and the subject reviewed. All other authors declare no competing interests.